Target intelligence / Profile preview

Blood group A antigen (A antigen)

Target
A antigen
Molecular classification
Carbohydrate, Glycan, Histo-blood group antigen
01

Overview

The Blood group A antigen is a terminal carbohydrate motif expressed on erythrocytes and epithelial tissues, defined by an N-acetylgalactosamine (GalNAc) residue linked to an H-antigen core. Synthesized by the ABO glycosyltransferase, it plays a critical role in transfusion medicine and transplantation, where incompatibility triggers severe immune responses mediated by naturally occurring anti-A antibodies. Beyond hematology, the A antigen acts as a co-receptor for pathogens like Norovirus and is associated with increased risks of cardiovascular events due to its influence on von Willebrand factor levels. In oncology, the loss or neo-expression of A-type motifs serves as a marker for tumor progression and altered cell signaling. Current therapeutic development focuses on universalizing blood through enzymatic cleavage of the GalNAc residue using recombinant glycosidases. These efforts aim to mitigate supply shortages and eliminate the risk of hemolytic transfusion reactions in emergency settings.

Other names
A-type blood group carbohydrate motifHisto-blood group A antigenGalNAc-alpha-1,3-(Fuc-alpha-1,2)-Gal-beta-RBlood group A substance
02

Mechanism of action

Enzymatic cleavage of the terminal N-acetylgalactosamine residue to convert A antigen to H antigen (O type); Antibody-mediated agglutination and hemolysis; Glycan masking to prevent immune recognition.

03

Biological functions

Cell-cell recognitionImmune responseCell adhesionPathogen binding receptor
04

Disease associations

Transfusion reactionHemolytic disease of the newbornInfectionCancerCardiovascular disease
05

Safety considerations

Acute hemolytic transfusion reactionHyperacute organ rejectionPotential for off-target enzymatic activity on other glycansIncomplete enzymatic conversion
06

Interacting drugs

Alpha-N-acetylgalactosaminidase

2 more in the full profile.

07

Biomarkers

ABO blood group statusAnti-A antibody titer

Beyond the preview

Go deeper on Blood group A antigen (A antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood group A antigen (A antigen).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call